$20 party, page-28

It is a choice we all have ADN.

I took your same choice before the FDA Daybue approval, because I was spooked by the Billy Dunn resignation on the death knock. Unfortunately you can't use hindsight after an event, so I was determined not to be disappointed if I had protected capital unnecessarily - which turned out to be the case. After the fact, it is still a bit difficult not to regret it, but I must tell myself I did the right thing at the time.

I can't say good luck with your choice, because I want a great result, but I respect you for taking that pathway. Obviously, as far as you are concerned, you have done the right thing - never regret it if it turns out to be unnecessary.

This time I am riding it out, because I consider Daybue alone is undervalued at the moment. A mediocre to poor PMS result may well drive us well down from here, but if Daybue continues to perform we should recover back to $16 and a fair % more, plus,
PMS result has an unusually high probability of success compared to statistical averages (IMOO) and
there are 3 more 2591 trials to come. The above is enough reason for me to risk my capital this time.

[However, IMO, we need an almost stellar PMS result to continue on the path to the moon which is frequently predicted.]